what are targeted drug delivery system?
242024
Targeted drug delivery, sometimes called smart drug delivery, is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others. ... Targeted drug delivery systems have been developed to optimize regenerative techniques.
1429043
Tyrosine Kinase Inhibitor (TKI) Therapy. Tyrosine kinase inhibitors (TKIs) are a type of targeted therapy. TKIs come as pills, taken orally. A targeted therapy identifies and attacks specific types of cancer cells while causing less damage to normal cells.
126519
Specialty drugs or specialty pharmaceuticals are a recent designation of pharmaceuticals that are classified as high-cost, high complexity and/or high touch. Specialty drugs are often biologics—"drugs derived from living cells" that are injectable or infused (although some are oral medications).
1256822
In addition to facilitating biomarker identification, such aptamers can be directly used for cell isolation, cell visualization, and tracking cells in vivo. They can also be used to modulate activities of cell receptors and deliver different agents (e.g., siRNA and drugs) into the cells.
322519
FDF : Fixed Dose Formulation. It is a combination of drugs with a fixed proportion set by the standard drug regulating authorities like FDA. API : Active pharmaceutical ingradient. ... It is a bulk drug from which branded/generic medicines are prepared.
131135
Radiation Therapy. Radiation therapy works much differently. While chemotherapy delivers drugs to the entire body, radiation aims to only target the specific area of the body where there are cancerous cells, and aims to reduce the number of healthy cells that are affected during treatment.
1150546
Immunotherapy is a new form of cancer treatment that uses the immune system to attack cancer cells. Interventional radiology involves minimally invasive techniques using needles and catheters, and provides an alternative to surgery for some patients.
1093390
GPCRs have been a major target for drug developers because of their regulation of a wide variety of human physiological processes, including growth, metabolism and homeostasis. ... In addition, drugs targeting GPCRs have shown that they can generate their effect without creating toxicity for normal cells.
279683
Specialty drugs are often biologics—"drugs derived from living cells" that are injectable or infused (although some are oral medications). They are used to treat complex or rare chronic conditions such as cancer, rheumatoid arthritis, hemophilia, H.I.V. psoriasis, inflammatory bowel disease and hepatitis C.
335379
Keytruda is the first drug of its kind to work in colon cancer. It is monoclonal antibody, which uses a patient's own cells to kill cancer by enabling the body's natural immune response to tumor cells. The catch is, however, this drug is only effective for a small group of patients.
863794
Tyrosine kinase inhibitors. Tyrosine kinase inhibitors (TKIs) are a class of chemotherapy medications that inhibit, or block, one or more of the enzyme tyrosine kinases. Cell membrane receptors are what scientists call molecular structures that send and receive signals from the environment.
388386
Targeted drugs suppress tumor growth. Targeted drugs only interact with cells they are designed to act on. Targeted drugs are designed to target and destroy specific cancer cells. Disruption of synthesis of DNA or DNA"s precursors is a non-specific action of cytotoxic drugs, which interfere with cell replication.
470084
Drug type: Nivolumab is a targeted therapy. It is a human programmed death receptor-1 (PD-1) blocking antibody.
1237988
Phosphodiesterase 5 (PDE 5) inhibitors are a type of targeted therapy used to treat people with pulmonary hypertension (PH).
769226
Indeed, numerous clinical trials are underway to evaluate the potential to combine immune checkpoint inhibitors (ICIs) and chemotherapies (6). Pemetrexed is an established chemotherapeutic that disrupts the folate pathway and is part of the standard of care for non-squamous NSCLC and mesothelioma (7).
124160
['trastuzumab (Herceptin)', 'pertuzumab (Perjeta)', 'bevacizumab (Avastin)', 'rituximab (Mabthera)']
694105
Drug product is the finished product of any drug that is available in the market and is ready to use (this includes it's packaging, see also below). A drug substance, because of multiple factors (sensitivity, stability, etc.) is required to be mixed with other components before being released for use in the market.